AnaptysBio's GAAP loss for 6M 2021 was $18.592 million, down 37.6% from $29.81 million in the previous year. Revenue increased 2.8 times to $41.274 million from $15 million a year earlier.
AnaptysBio's GAAP loss for 6M 2021 was $18.592 million, down 37.6% from $29.81 million in the previous year. Revenue increased 2.8 times to $41.274 million from $15 million a year earlier. 
ir.anaptysbio.com
English (US) 